Impaired clearance of oxidised proteins in neurodegenerative diseases [2]

Lancet

Volumn 351, Issue 9114, 1998, Pages 1510-

  Halliwell, B ^a   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; FREE RADICAL; LIPID; MUTANT PROTEIN; PROTEASOME; PROTEIN;

ALZHEIMER DISEASE; BIOACCUMULATION; CELL NUCLEUS; CLEARANCE; DEGENERATIVE DISEASE; HUMAN; LETTER; OXIDATION; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SUBSTANTIA NIGRA;

EID: 18544400489     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78898-X     Document Type: Letter

References (5)

1. M Larkin Therapeutic target reveals itself in diseased neurons Lancet 351 1998 424
2. CD Smith JM Carney PE Starke-Reed Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease Proc NatlAcad Sci USA 88 1997 10540 10543
3. ZI Alam SE Daniel AJ Lees DC Marsden P Jenner B Halliwell Generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J Neurochem 69 1997 1326 1329
4. T Grune KJA Davies Breakdown of oxidized proteins as a part of secondary antioxidant defences in mammalian cells Biofactors 6 1997 165 172
5. M Conconi B Friguet Proteasome inactivation upon ageing and on oxidation— effect of HSP 90 Mol Biol Rep 24 1997 45 50